Evidence map›Paper›PMID 41860245›Full record

ArticleEuropean journal of neurology2026

Paramagnetic Rim Lesions in Highly Active Multiple Sclerosis at the Time of Disease Diagnosis: Prevalence Data and Clinical Implications.

Alessandra Cicia, Matteo Lucchini, Gianluca Di Fiore, Luca Ausili Cefaro, Assunta Bianco, Viviana Nociti, Vincenzo Carlomagno, Simona Gaudino, Massimiliano Mirabella

Abstract read
In one paragraph

Article in European journal of neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Alessandra CiciaCentro di Ricerca Per la Sclerosi Multipla "Anna Paola Batocchi", Department of Neurosciences, Università Cattolica del Sacro Cuore, Rome, Italy.
Matteo LucchiniCentro di Ricerca Per la Sclerosi Multipla "Anna Paola Batocchi", Department of Neurosciences, Università Cattolica del Sacro Cuore, Rome, Italy.
Gianluca Di FioreDepartment of Diagnostic Imaging, Radiation Oncology and Hematology, Fondazione Policlinico Universitario "Agostino Gemelli" IRCCS, Rome, Italy.
Luca Ausili CefaroDepartment of Diagnostic Imaging, Radiation Oncology and Hematology, Fondazione Policlinico Universitario "Agostino Gemelli" IRCCS, Rome, Italy.
Assunta BiancoMultiple Sclerosis Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Viviana NocitiMultiple Sclerosis Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Vincenzo CarlomagnoCentro di Ricerca Per la Sclerosi Multipla "Anna Paola Batocchi", Department of Neurosciences, Università Cattolica del Sacro Cuore, Rome, Italy.
Simona GaudinoDepartment of Diagnostic Imaging, Radiation Oncology and Hematology, Fondazione Policlinico Universitario "Agostino Gemelli" IRCCS, Rome, Italy.
Massimiliano MirabellaCentro di Ricerca Per la Sclerosi Multipla "Anna Paola Batocchi", Department of Neurosciences, Università Cattolica del Sacro Cuore, Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundParamagnetic rim lesions (PRLs) are emerging MRI biomarkers of smoldering inflammation in multiple sclerosis with prognostic relevance

objectiveThis prospective cohort study investigated the prevalence, anatomical distribution, and clinical significance of PRLs in newly diagnosed relapsing MS patients with high disease activity and explored their associations with conventional and non-conventional MRI measures, serum neurofilament light chain (sNfL), and clinical outcomes.

methodsWe enrolled treatment-naïve patients who had received an MS diagnosis in the previous 12 months. Patients underwent 3 T brain and spinal MRI including susceptibility-weighted imaging at baseline, 6, and 12 months, along with neurological and cognitive assessments and sNfL sampling.

resultsThe cohort consisted of 21 patients, with a mean age of 31 and median disease duration of 9 months (IQR 4-17). Median EDSS score was 1.5. All patients presented with spinal cord lesions and 38% showed Gd + lesions. PRLs were detected in 76%, with a mean of 4.9 lesions per subject. Higher PRL burden correlated with greater T2 lesion volume and cortical lesion count, higher EDSS, reduced SDMT scores, and elevated baseline sNfL. PRLs remained stable over 12 months despite treatment; two new PRLs emerged at month 12. sNfL levels were higher in patients with ≥ 4 PRLs and decreased in all during follow-up.

conclusionsParamagnetic rim lesions (PRLs) are detectable early in RMS and correlate with a more severe clinical and radiological profile. The combined assessment of PRLs and CLs may improve disease monitoring and guide personalized treatment.

Indexed as

BrainMultiple SclerosisMultiple Sclerosis, Relapsing-RemittingSpinal CordAdultFemaleHumansMagnetic Resonance ImagingMaleNeurofilament ProteinsPrevalenceProspective Studiesneurofilament protein LNeurofilament Proteinscortical lesionsMRIparamagnetic rim lesionssmoldering multiple sclerosissNfL

Identifiers

PMID41860245
PMCPMC13093696

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.